Scarica l'app Stockscreener
5.25
3.62%
0.12
Precedente Chiudi:
$5.13
Aprire:
$5.13
Volume 24 ore:
845.02K
Relative Volume:
0.41
Capitalizzazione di mercato:
$821.80M
Reddito:
$181.41M
Utile/perdita netta:
$-59.56M
Rapporto P/E:
-12.50
EPS:
-0.42
Flusso di cassa netto:
$-38.83M
1 W Prestazione:
+2.82%
1M Prestazione:
+13.83%
6M Prestazione:
+49.32%
1 anno Prestazione:
+114.34%
Intervallo 1D:
$5.0801
$5.34
Intervallo di 1 settimana:
$4.9447
$5.34
Portata 52W:
$2.095
$6.07
Xeris Biopharma Holdings Inc Stock (XERS) Company Profile
Nome
Xeris Biopharma Holdings Inc
Settore
Industria
Telefono
844-445-5704
Indirizzo
1375 WEST FULTON STREET, SUITE 1300, CHICAGO, IL
Confronta XERS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
XERS
Xeris Biopharma Holdings Inc
|
5.255 | 800.78M | 181.41M | -59.56M | -38.83M | -0.42 |
|
VRTX
Vertex Pharmaceuticals Inc
|
467.49 | 120.29B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
555.53 | 60.26B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
393.30 | 43.10B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
678.88 | 36.65B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
301.63 | 33.09B | 3.81B | -644.79M | -669.77M | -6.24 |
Xeris Biopharma Holdings Inc Stock (XERS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-11-11 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2024-03-28 | Iniziato | Oppenheimer | Outperform |
| 2023-08-28 | Iniziato | Craig Hallum | Buy |
| 2022-10-21 | Iniziato | Jefferies | Buy |
| 2022-04-28 | Iniziato | Craig Hallum | Buy |
| 2021-11-17 | Iniziato | SVB Leerink | Outperform |
| 2021-10-29 | Iniziato | H.C. Wainwright | Buy |
| 2021-04-07 | Ripresa | RBC Capital Mkts | Outperform |
| 2020-02-18 | Iniziato | Piper Sandler | Overweight |
| 2018-07-16 | Iniziato | Jefferies | Buy |
| 2018-07-16 | Iniziato | Leerink Partners | Outperform |
| 2018-07-16 | Iniziato | RBC Capital Mkts | Outperform |
Mostra tutto
Xeris Biopharma Holdings Inc Borsa (XERS) Ultime notizie
Xeris Biopharma to Report Second Quarter 2025 Financial Results on August 7, 2025 - Business Wire
How strong is Xeris Biopharma Holdings Inc. company’s balance sheetStock Strategy Trend Scanner For Every Investor - jammulinksnews.com
What makes Xeris Biopharma Holdings Inc. stock price move sharplyFree Market Momentum and Signal Alerts - Newser
AI Trend Models Suggest Bounce for Xeris Biopharma Holdings Inc.Conservative Long Term Growth Plans Under Review - metal.it
Why Xeris Biopharma Holdings Inc. stock attracts strong analyst attentionFundamental + Technical Hybrid Stock Tips Shared - metal.it
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) is a favorite amongst institutional investors who own 54% - Yahoo.co
How did XERS's Q4 earnings surprise impact investor confidence? - AInvest
Xeris Biopharma Holdings Inc. Stock Support and Resistance Levels You Should KnowLong-Term Investment Strategy Impact Analysis - Newser
Is Xeris Biopharma Holdings Inc. Stock a Good Fit for Conservative InvestorsFree Stock Market Watch With Alerts - Newser
Can momentum traders help lift Xeris Biopharma Holdings Inc.Daily Technical Forecast for Quick Gains - Newser
Xeris Biopharma Holdings Inc. stock daily chart insightsSafe Investment Ideas with Growth Upside - Newser
Trend Dashboard Flags Xeris Biopharma Holdings Inc. As Potential Swing TradeBreakout Momentum Picks With Protection Outlined - metal.it
What are Xeris Biopharma Holdings Inc. company’s key revenue driversBreakout Stocks Opportunities Backed By Experts - jammulinksnews.com
Is it the right time to buy Xeris Biopharma Holdings Inc. stockAchieve superior capital gains with smart trades - jammulinksnews.com
What are the latest earnings results for Xeris Biopharma Holdings Inc.Accelerated earnings growth - jammulinksnews.com
Is Xeris Biopharma Holdings Inc. a growth stock or a value stockSuperior capital gains - jammulinksnews.com
New York State Common Retirement Fund Boosts Stake in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World
Cwm LLC Increases Stock Position in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World
What analysts say about Xeris Biopharma Holdings Inc. stockTremendous return rates - PrintWeekIndia
Is Xeris Biopharma Holdings Inc. a good long term investmentDouble or triple returns - PrintWeekIndia
Will Xeris Biopharma Holdings Inc. stock split in the near futureGame-changing capital returns - jammulinksnews.com
Xeris Biopharma Holdings Inc. Stock Analysis and ForecastFree Investment Case Studies - PrintWeekIndia
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Receives Average Recommendation of “Moderate Buy” from Brokerages - Defense World
What drives Xeris Biopharma Holdings Inc. stock pricePowerful profit generation - jammulinksnews.com
How Xeris Biopharma Holdings Inc. stock performs during market volatilitySmall Risk Large Return Trades - Newser
Xponance Inc. Invests $57,000 in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World
Xeris Biopharma Holdings Inc Azioni (XERS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.69%
0.79%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):